Is Alexion Pharmaceuticals (NASDAQ:ALXN) Stock A Good Investment?

With Soliris prediction through 2018, we explore whether Alexion Pharmaceuticals (NASDAQ:ALXN) is a good investment opportunity.

Posted in HADE Platform, Healthcare & Biotech, Members | Tagged , | Leave a comment

7 Laggards That Are Bargains In 2017: SHLD, GNC, CLDX, HBI, ALXN

Sears (SHLD), Noodles (NDLS), Celldex Therapeutics (CLDX), Hanesbrands (HBI), CPI Card (PMTS), GNC, & Alexion (ALXN) are laggards with turnaround potential.

Posted in Members, Portfolio Strategy, Timely Analysis | Tagged , , , , , , , , , , , , , | 1 Comment

Why Sarepta Therapeutics (SRPT) Stock Will Double Over Next 12-Months

Sarepta Therapeutics investors should not worry about the FDA or a slow launch for Exondys 51; investors should expect SRPT stock soar short-term.

Posted in BNL Reports, Healthcare & Biotech | Tagged , , , , , , , | Leave a comment

Why Hillary Clinton Is Bad News For Gilead Stock & Biotechnology (NASDAQ:GILD)

Gilead stock is one of many in biotechnology that could face Hillary Clinton’s wrath when and if she is elected President.

Posted in Healthcare & Biotech, Politics | Tagged , , , , , , , , , , , , , , , , , | Leave a comment